CSF neurofilament light chain in multiple sclerosis and its subtypes: a meta-analysis of case control studies

被引：0
|
作者：
Martin, S. -J. [1 ,2 ]
McGlasson, S. [3 ,4 ]
Hunt, D. [3 ,4 ]
Overell, J. [2 ,5 ]
机构：
[1] Ann Rowling Ctr Regenerat Neurol, Edinburgh, Midlothian, Scotland
[2] Univ Glasgow, Glasgow, Lanark, Scotland
[3] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland
[4] Univ Edinburgh, MRC Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland
[5] Queen Elizabeth Univ Hosp, Glasgow Multiple Sclerosis Clin Res Ctr, Glasgow, Lanark, Scotland
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1171
引用
收藏
页码：658 / 658
页数：1
相关论文
共 50 条
  • [1] Cerebrospinal fluid neurofilament light chain in multiple sclerosis and its subtypes: a meta-analysis of case-control studies
    Martin, Sarah-Jane
    McGlasson, Sarah
    Hunt, David
    Overell, James
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (09): : 1059 - 1067
  • [2] Neurofilament light chain as a biological marker for multiple sclerosis: a meta-analysis study
    Cai, Laisheng
    Huang, Jingwei
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2018, 14 : 2241 - 2254
  • [3] The interaction between exercise and neurofilament light chain in multiple sclerosis: a systematic review and meta-analysis
    Salamatullah, Hassan K.
    Alkhiri, Ahmed
    Ezzi, Suzana
    Alghamdi, Ghidaa
    Alharbi, Ghadi
    Alzahrani, Waleed S.
    Alghaythee, Himyan Kamel
    Almaghrabi, Ahmed A.
    Alturki, Fahad
    Alamri, Aser F.
    Makkawi, Seraj
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 90
  • [4] Neurofilament light chain in blood as a diagnostic and predictive biomarker for multiple sclerosis: A systematic review and meta-analysis
    Ning, Liangxia
    Wang, Bin
    PLOS ONE, 2022, 17 (09):
  • [5] Social cognition in multiple sclerosis and its subtypes: A meta-analysis
    Lin, XiaoGuang
    Zhang, XueLing
    Liu, QinQin
    Zhao, PanWen
    Zhong, JianGuo
    Pan, PingLei
    Wang, GenDi
    Yi, ZhongQuan
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 52
  • [6] CSF Neurofilament Light Chain for guiding individual treatment decisions in multiple sclerosis
    Smets, I.
    Reyes, S.
    Carrillo-Loza, K.
    Mateo-Casas, M.
    Bianchi, L.
    Holden, D.
    Ammoscato, F.
    Turner, B.
    Schmierer, K.
    Marta, M.
    Giovannoni, G.
    Gnanapavan, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 475 - 476
  • [7] CSF neurofilament light chain provides a valuable prognostic tool in multiple sclerosis
    Leitao, M. J.
    Pascoal, R.
    Ribeiro, M. H.
    Correia, I.
    Batista, S.
    Sousa, L.
    Baldeiras, I.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 835 - 836
  • [8] Neurofilament light chain as a biological marker for amyotrophic lateral sclerosis: a meta-analysis study
    Sferruzza, Giacomo
    Bosco, Luca
    Falzone, Yuri Matteo
    Russo, Tommaso
    Domi, Teuta
    Quattrini, Angelo
    Filippi, Massimo
    Riva, Nilo
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2022, 23 (5-6) : 446 - 457
  • [9] Correlation between CSF and blood neurofilament light chain protein: a systematic review and meta-analysis
    Alagaratnam, Jasmini
    von Widekind, Sophia
    De Francesco, Davide
    Underwood, Jonathan
    Edison, Paul
    Winston, Alan
    Zetterberg, Henrik
    Fidler, Sarah
    BMJ NEUROLOGY OPEN, 2021, 3 (01)
  • [10] CSF neurofilament light chain levels are markedly reduced by fingolimod in relapsing multiple sclerosis
    Kuhle, J.
    Stites, T.
    Chen, Y.
    Dahlke, F.
    Francis, G.
    Sfikas, N.
    Radue, E. -W.
    Giovannoni, G.
    Kappos, L.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 559 - 560
12345